Evidence map›Paper›PMID 35985821›Full record

Observational studyNeurology2022

Structural Neuroimaging in Adults and Adolescents With Newly Diagnosed Focal Epilepsy: The Human Epilepsy Project.

Anna M Bank, Ruben Kuzniecky, Robert C Knowlton, Gregory D Cascino, Graeme Jackson, Heath R Pardoe, Human Epilepsy Project Investigators

Erratum issuedOpen access · greenAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Quantitative dual-tracerEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Anna M BankFrom the Department of Neurology (A.M.B., R.K.), Lenox Hill Hospital/Northwell Health, New York City; Department of Neurology (A.M.B., R.K.), Zucker School of Medicine at Hofstra University, Hempstead, NY; Department of Neurology (R.C.K.), University of California, San Francisco; Department of Neurology (G.D.C.), Mayo Clinic, Rochester, MN; Florey Institute for Neuroscience and Mental Health (G.J.), Parkville, Australia; and Department of Neurology (H.R.P.), New York University School of Medicine.ORCID 0000-0001-7450-8438
Ruben KuznieckyFrom the Department of Neurology (A.M.B., R.K.), Lenox Hill Hospital/Northwell Health, New York City; Department of Neurology (A.M.B., R.K.), Zucker School of Medicine at Hofstra University, Hempstead, NY; Department of Neurology (R.C.K.), University of California, San Francisco; Department of Neurology (G.D.C.), Mayo Clinic, Rochester, MN; Florey Institute for Neuroscience and Mental Health (G.J.), Parkville, Australia; and Department of Neurology (H.R.P.), New York University School of Medicine.
Robert C KnowltonFrom the Department of Neurology (A.M.B., R.K.), Lenox Hill Hospital/Northwell Health, New York City; Department of Neurology (A.M.B., R.K.), Zucker School of Medicine at Hofstra University, Hempstead, NY; Department of Neurology (R.C.K.), University of California, San Francisco; Department of Neurology (G.D.C.), Mayo Clinic, Rochester, MN; Florey Institute for Neuroscience and Mental Health (G.J.), Parkville, Australia; and Department of Neurology (H.R.P.), New York University School of Medicine.
Gregory D CascinoFrom the Department of Neurology (A.M.B., R.K.), Lenox Hill Hospital/Northwell Health, New York City; Department of Neurology (A.M.B., R.K.), Zucker School of Medicine at Hofstra University, Hempstead, NY; Department of Neurology (R.C.K.), University of California, San Francisco; Department of Neurology (G.D.C.), Mayo Clinic, Rochester, MN; Florey Institute for Neuroscience and Mental Health (G.J.), Parkville, Australia; and Department of Neurology (H.R.P.), New York University School of Medicine.
Graeme JacksonFrom the Department of Neurology (A.M.B., R.K.), Lenox Hill Hospital/Northwell Health, New York City; Department of Neurology (A.M.B., R.K.), Zucker School of Medicine at Hofstra University, Hempstead, NY; Department of Neurology (R.C.K.), University of California, San Francisco; Department of Neurology (G.D.C.), Mayo Clinic, Rochester, MN; Florey Institute for Neuroscience and Mental Health (G.J.), Parkville, Australia; and Department of Neurology (H.R.P.), New York University School of Medicine.ORCID 0000-0002-7917-5326
Heath R PardoeFrom the Department of Neurology (A.M.B., R.K.), Lenox Hill Hospital/Northwell Health, New York City; Department of Neurology (A.M.B., R.K.), Zucker School of Medicine at Hofstra University, Hempstead, NY; Department of Neurology (R.C.K.), University of California, San Francisco; Department of Neurology (G.D.C.), Mayo Clinic, Rochester, MN; Florey Institute for Neuroscience and Mental Health (G.J.), Parkville, Australia; and Department of Neurology (H.R.P.), New York University School of Medicine.ORCID 0000-0002-0123-2167
Human Epilepsy Project Investigators
Mayo Clinic · USHofstra University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesIdentification of an epileptogenic lesion on structural neuroimaging in individuals with focal epilepsy is important for management and treatment planning. The objective of this study was to determine the frequency of MRI-identified potentially epileptogenic structural abnormalities in a large multicenter study of adolescent and adult patients with newly diagnosed focal epilepsy.

methodsPatients with a new diagnosis of focal epilepsy enrolled in the Human Epilepsy Project observational cohort study underwent 3 T brain MRI using a standardized protocol. Imaging findings were classified as normal, abnormal, or incidental. Abnormal findings were classified as focal or diffuse and as likely epilepsy-related or of unknown relationship to epilepsy. Fisher exact tests were performed to determine whether abnormal imaging or abnormality type was associated with clinical characteristics.

resultsA total of 418 participants were enrolled. Two hundred eighteen participants (59.3%) had no abnormalities detected, 149 (35.6%) had abnormal imaging, and 21 (5.0%) had incidental findings. Seventy-eight participants (18.7%) had abnormalities that were considered epilepsy-related, and 71 (17.0%) had abnormalities of unknown relationship to epilepsy. Older participants were more likely to have imaging abnormalities, while participants with focal and epilepsy-related imaging abnormalities were younger than those without these abnormalities. One hundred thirty-one participants (31.3%) had a family history of epilepsy. Epilepsy-related abnormalities were not associated with participant sex, family history of epilepsy, or seizure type. DISCUSSION: We found that 1 in 5 patients with newly diagnosed focal epilepsy has an MRI finding that is likely causative and may alter treatment options. An additional 1 in 5 patients has abnormalities of unknown significance. This information is important for patient counseling, prognostication, and management.

Indexed as

Epilepsies, PartialEpilepsyAdolescentAdultHumansMagnetic Resonance ImagingNeuroimagingSeizures

Identifiers

PMID35985821
PMCPMC9651452
OpenAlexW4292354354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.